Index firms write off Russian stocks
Russian stocks will be removed from MSCI’s main emerging markets index at a price that is effectively zero.
Stock indices are a crucial feature of the global financial landscape, says Sydney Maki on Bloomberg. They are “followed on autopilot by trillions of dollars in passive investments, and used as a benchmark for trillions more in active strategies”. More than $16trn globally is thought to be benchmarked to indexes compiled by MSCI, and inclusion in these is “an important symbol of acceptance in the mainstream global financial community”.
So the news that Russian stocks will be removed from MSCI’s main emerging markets index at a price that is effectively zero., in the firm’s own words, is highly significant: it shows how Russia has been “cut off from large swathes of the investing world”, says Maki. Sanctions, the closure of the Moscow stock exchange and a ban on foreigners selling assets locally mean that the market is essentially uninvestable, says the Financial Times. Other index providers, such as FTSE Russell and S&P Dow Jones, plus investment bank JPMorgan, which produces several key emerging-market bond benchmarks, are also removing Russian assets from their indices.
Unless investors have taken specific bets on Russia they are unlikely to notice big losses from the index writedowns. Russian stocks made up less than 4% of the MSCI Emerging Markets index at the start of the year, a sharp drop from 2008 – when it accounted for 10%. The Universities Superannuation Scheme, Britain’s biggest private pension plan, has just 0.5% or so of its portfolio in Russian-connected assets.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Still, as Hermitage Capital Management’s co-founder Bill Browder says, the sudden dash to sell near-worthless Russian securities is “a reminder that if you do business in countries without a rule of law, you could lose everything”.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Alex Rankine is Moneyweek's markets editor
-
Twenty 'finfluencers' questioned under caution by the UK regulator
The individuals were interviewed voluntarily using the Financial Conduct Authority’s criminal powers
By Chris Newlands Published
-
Number of ISA millionaires triples in three years
The number of people with £1 million in their ISAs has tripled in three years to reach 3,180. But could next week’s Budget put an end to future ISA millionaires?
By Ruth Emery Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
Modi’s reforms set Indian stocks on fire
Indian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
By Alex Rankine Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published